This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Apr 2;321(13):1258-1260.

doi: 10.1001/jama.2019.1998.

Amyloid PET and Changes in Clinical Management for Patients With Cognitive Impairment

Clifford R Jack Jr¹, Ronald C Petersen²

Affiliations

PMID: 30938781
DOI: 10.1001/jama.2019.1998

Editorial

Amyloid PET and Changes in Clinical Management for Patients With Cognitive Impairment

Clifford R Jack Jr et al. JAMA. 2019.

. 2019 Apr 2;321(13):1258-1260.

doi: 10.1001/jama.2019.1998.

Authors

Clifford R Jack Jr¹, Ronald C Petersen²

Affiliations

¹ Department of Radiology, Mayo Clinic, Rochester, Minnesota.
² Department of Neurology, Mayo Clinic, Rochester, Minnesota.

PMID: 30938781
DOI: 10.1001/jama.2019.1998

No abstract available

PubMed Disclaimer

Comment on

Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.
Rabinovici GD, Gatsonis C, Apgar C, Chaudhary K, Gareen I, Hanna L, Hendrix J, Hillner BE, Olson C, Lesman-Segev OH, Romanoff J, Siegel BA, Whitmer RA, Carrillo MC. Rabinovici GD, et al. JAMA. 2019 Apr 2;321(13):1286-1294. doi: 10.1001/jama.2019.2000. JAMA. 2019. PMID: 30938796 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information